umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Identification of Lys178 as the acceptor lysine of TGF-beta type I receptor poly-ubiquitination.
Umeå University, Faculty of Medicine, Department of Medical Biosciences. (Marene Landström Group)
Umeå University, Faculty of Medicine, Department of Medical Biosciences. (Marene Landström Group)ORCID iD: K-8186-2013
Ludwig Institute for Cancer Research, Uppsala University.
Umeå University, Faculty of Medicine, Department of Medical Biosciences.
(English)Manuscript (preprint) (Other academic)
National Category
Cancer and Oncology
Research subject
Oncology
Identifiers
URN: urn:nbn:se:umu:diva-87057OAI: oai:DiVA.org:umu-87057DiVA: diva2:705849
Available from: 2014-03-18 Created: 2014-03-18 Last updated: 2014-03-19Bibliographically approved
In thesis
1. TRAF6 stimulates TGFβ-induced oncogenic signal transduction in cancer cells
Open this publication in new window or tab >>TRAF6 stimulates TGFβ-induced oncogenic signal transduction in cancer cells
2014 (English)Doctoral thesis, comprehensive summary (Other academic)
Alternative title[sv]
TRAF6 stimulerar TGFβ-inducerad onkogen signal transduction i cancerceller.
Abstract [en]

Prostate cancer is one of the leading causes of cancer-related deaths in men worldwide, with 10,000 new cases/year diagnosed in Sweden. In this context, there is an urgent need to identify new biomarkers to detect prostate cancer at an initial stage for earlier treatment intervention. Although how prostate cancer develops has not been fully established, the male sex hormone testosterone is a known prerequisite for prostate cancer development. High levels of transforming growth factor-β (TGFβ) are prognostically unfavorable in prostate cancer patients.

TGFβ is a multifunctional cytokine that regulates a broad range of cellular responses. TGFβ signals through either the canonical Smad or the non-Smad signaling cascade. Cancerous cells develop different strategies to evade defense mechanisms and metastasize to different parts of the body. This thesis unveils one such novel mechanism related to TGFβ signaling.

The first two articles provide evidence that TGFβ receptor type I (TβRI) is ubiquitinated by tumor necrosis factor receptor-associated factor 6 (TRAF6) and is cleaved at the ectodomain region by tumor necrosis factor alpha converting enzyme (TACE) in a protein kinase C zeta type-dependent manner. After TβRI is shed from the ectodomain, it undergoes a second cleavage by presenilin 1 (PS1), a γ-secretase catalytic subunit, which liberates the TβRI intracellular domain (TβRI-ICD) from the cell membrane. TRAF6 promotes TGFβ-dependent Lys63-linked polyubiquitination and recruitment of PS1 to the TβRI complex, and facilitates the cleavage of TβRI by PS1 to generate a TβRI-ICD. The TβRI-ICD then translocates to the nucleus, where it binds with the transcriptional co-activator p300 and regulates the transcription of pro-invasive target genes such as Snail1. Moreover, the nuclear translocated TβRI-ICD cooperates with the Notch intracellular domain (NICD), a core component in the Notch signaling pathway, to drive the expression of invasive genes. Interestingly, treatment with g-secretase inhibitors was able to inhibit cleavage of TβRI and inhibit the TGFβ-induced oncogenic pathway in an in vivo prostate cancer xenograft model.

In the third article, we identified that Lysine 178 is the acceptor lysine in TβRI that is ubiquitinated by TRAF6. The TβRI K178R mutant was neither ubiquitinated nor translocated to the nucleus, and prevented transcriptional regulation of invasive genes in a dominant negative manner.

In the fourth article, we show that TGFβ utilizes the E3-ligase TRAF6 and the p38 mitogen-activated protein kinase to phosphorylate c-Jun. In turn, the phosphorylated c-Jun activates p21 and Snail1 in a non-canonical Smad-independent pathway, and thereby promotes invasion in cancerous cells.

In summary, we elucidate a new mechanism of TGFβ-induced oncogenic signal transduction in cancer cells in which TRAF6 plays a fundamental role. This opens a new avenue in the field of TGFβ signaling.

Place, publisher, year, edition, pages
Umeå: Umeå University, 2014. 70 p.
Series
Umeå University medical dissertations, ISSN 0346-6612 ; 1638
Keyword
c-Jun, invasion, non-Smad, Notch, NICD, oncogenesis, presenilin1, PKCζ, prostate cancer, p21, p38, p300, Snail1, TGFβ, TβRI, TACE, TRAF6, ubiquitination, TGFbeta signal transduction
National Category
Cancer and Oncology
Research subject
Pathology
Identifiers
urn:nbn:se:umu:diva-87017 (URN)978-91-7601-025-9 (ISBN)
Public defence
2014-04-11, Hörsal E 04, Unod R1, Norrlands universitetssjukhus, Umeå, 10:15 (English)
Opponent
Supervisors
Funder
Swedish Cancer SocietySwedish Research Council
Available from: 2014-03-19 Created: 2014-03-18 Last updated: 2014-03-19Bibliographically approved

Open Access in DiVA

No full text

Authority records BETA

Sundar, ReshmaGudey, Shyam KumarLandström, Marene

Search in DiVA

By author/editor
Sundar, ReshmaGudey, Shyam KumarLandström, Marene
By organisation
Department of Medical Biosciences
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 91 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf